Ethyl 5-(3,5-difluorophenyl)-5-oxovalerate, 97.0%, 1g

2-(4-bromophenyl)-N-methylacetamide, 95.0%, 10g

5-bromo-1-(methylsulfonyl)indoline, 98.0%, 1g

tert-Butyl N-[1-(4-aminophenyl)azetidin-3-yl]carbamate, 98%, 100mg

4-tert-Butylphenyl glycidyl ether, 98.0%, 100g

5-Nitrobenzo[d][1,2,3]thiadiazole, 98%, 1g

1-Chloro-2-nitro-4-(trifluoromethoxy)benzene, 95.0%, 5g

Solution étalon de baryum ICP, 500 mL, 10 000 mg/L Ba, HDPE

2-(2,5-Dimethyl-1H-pyrrol-1-yl)phenylamine, 1g

Combretastatin A4, 98.0%, 25mg

(R)-1-(2-Chloro-5-fluoropyridin-3-yl)ethanol, 98%, 250mg

Methyl 4-cyano-2-methylbenzoate, 95.0%, 100g

(R)-(-)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine>98.0%(HPLC)(N)1g